Evaluating Candidate Principal Surrogate Endpoints
From MaRDI portal
Publication:3549407
DOI10.17615/sya7-f487 10.1111/j.1541-0420.2008.01014.x; 10.17615/sya7-f487zbMath1152.62389MaRDI QIDQ3549407
Peter B. Gilbert, Michael G. Hudgens
Publication date: 22 December 2008
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc2726718
clinical trial; causal inference; principal stratification; structural model; Prentice criteria; HIV vaccine; case cohort; postrandomization selection bias
62P10: Applications of statistics to biology and medical sciences; meta analysis
92C50: Medical applications (general)
62N02: Estimation in survival analysis and censored data
Related Items
A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint, A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework, Rejoinder, Discussion on “Surrogate Measures and Consistent Surrogates”, Discussion on “Surrogate Measures and Consistent Surrogates”, Assessing Vaccine Effects in Repeated Low‐Dose Challenge Experiments, Evaluation of longitudinal surrogate markers, A unified evaluation of differential vaccine efficacy, Robust methods to correct for measurement error when evaluating a surrogate marker, Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy, Testing for Heterogeneity in the Utility of a Surrogate Marker, Assessing the value of a censored surrogate outcome, A causal framework for surrogate endpoints with semi-competing risks data, Causal inference: a missing data perspective, Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy, Identification of causal effects within principal strata using auxiliary variables, Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption, Bayesian methods for multiple mediators: relating principal stratification and causal mediation in the analysis of power plant emission controls, Exploiting multiple outcomes in Bayesian principal stratification analysis with application to the evaluation of a job training program, An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference, Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials, Using Secondary Outcomes to Sharpen Inference in Randomized Experiments With Noncompliance, Surrogate Measures and Consistent Surrogates, Comparing Biomarkers as Principal Surrogate Endpoints, Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials, Augmented Designs to Assess Principal Strata Direct Effects, Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling, On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints, A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials
Cites Work
- An analytic method for randomized trials with informative censoring. I
- Principal Stratification in Causal Inference
- A case-cohort design for epidemiologic cohort studies and disease prevention trials
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Evaluating the Predictiveness of a Continuous Marker
